• New Treatment Option for Graves’ Disease Finally ‘On the Horizon’

    Sep 12 | Clinical Research News | Later this year, Immunovant will be launching a late-stage clinical trial for Graves’ disease—the first in a very, very long time. The preferred treatment option currently is methimazole, approved for medical use in the U.S. in 1950, but some patients require high doses of the drug to control their hyperthyroidism, and in up to half of cases long-term remission isn’t achievable short of surgery to remove the thyroid gland or radioactive iodine to destroy the thyroid and stop it from producing hormones. More

  • Closing the Gender Diagnostic Gap With a Sample-Collecting Tampon

    Sep 10 | Clinical Research News | Women’s health startup Daye is on a mission to bridge the gender diagnostic gap with a tampon for the self-collection of vaginal and cervical fluids analyzed for biomarkers of sexually transmitted infections (STIs), including human papillomavirus (HPV). The tampon is a familiar device used by over 90% of the female population and much better suited to their anatomy than conventional vaginal swabs. More

  • uMotif Buys ClinOne

    Sep 09 | Clinical Research News | uMotif has acquired site platform provider ClinOne. The acquisition is the logical next step in a successful two-year strategic partnership between the companies to leverage a single, integrated solution for electronic clinical outcomes assessments (eCOA) and electronic informed consent (eConsent) technology. Financial details were not released. More

  • SEQSTER and PatientsLikeMe Partner for Connected Patient Hub With Real-Time EHR Data

    Sep 05 | Clinical Research News | SEQSTER and United Healthcare Group’s PatientsLikeMe (PLM) announced their strategic partnership to accelerate the patient screening process, improve the patient onboarding experience to increase retention and engagement, and provide more resources and tools for condition-specific communities. More

  • Quality of Life Measures to Become Commonplace in Cancer Clinical Trials

    Sep 03 | Clinical Research News | A first-ever nationwide clinical trial examining the health-related quality of life (QoL) trajectory of young Hodgkin lymphoma patients undergoing treatment is “on the cusp of a new wave of measurement that is far more accessible and interpretable” for cancer patients and their physicians than clinical measures like number of relapses and overall survival. More

  • Follow the Money: Oncology, Autoimmunity, Breast, Prostate Clinical Trials, T Cell Products, More

    Aug 29 | Clinical Research News | Third Arc Bio plan to advance through clinical studies to address significant unmet needs in oncology and autoimmunity; Halda Therapeutics are looking to advance two RIPTAC candidates into clinical trials for patients with prostate cancer and breast cancer; Outpace Bio will advance multiple programmed T cell product candidates to early clinical proof-of-concept for the treatment of solid tumors; and more. More

  • Easing Pancreatic Cancer Clinical Trials, Training the Scientists of Tomorrow, More

    Aug 28 | Clinical Research News | myTomorrows and Pancreatic Cancer Europe have announced a new partnership to equip patients, caregivers, and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them; the National Institutes of Health has awarded the Ohio State University a $4.38 million grant to support newly trained clinician-scientists for careers in medical research; and more. More

  • Walgreens and BARDA Enter Partnership to Progress Decentralized Clinical Research Program

    Aug 27 | Clinical Research News | On Monday last week, Walgreens and the Biomedical Advanced Research and Development Authority (BARDA), a part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), announced a strategic partnership to further the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program. More

  • Fighting the Next Emerging Viral Outbreak: Key Ways to Improve Vaccine Access in Low-to-Middle-Income Countries

    Aug 23 | Clinical Research News | n a post-pandemic environment, we know the emergence of another viral risk is inevitable. As such, the broader healthcare ecosystem has evaluated insights from drug development efforts in recent years to develop a shared focus on improving vaccine readiness and equitable access by populations of low-to-middle income countries, or “LMICs.” More

  • NIH Launches Native Collective Research Effort Focused on Overdose

    Aug 20 | Clinical Research News | Last week, the National Institutes of Health (NIH) has launched the Native Collective Research Effort to Enhance Wellness (N CREW) Program, an effort support Native American communities to lead public health research to address overdose, substance use, and pain, including related factors such as mental health and wellness. The planned program funding totals approximately $268 million over seven years. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More